AbbVie nabs pediatric OK for hep C drug Mavyret; Glenmark launches cheaper SGLT2 inhibitor in India
→ Building off a surprise success with Mavyret in adults, AbbVie has nabbed an FDA approval to market …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.